遗传性心律失常综合征从儿科到成人的过渡管理
本文综述遗传性心律失常综合征(IAS)患者从青春期到成人期过渡与转接的复杂性,提出实用过渡路径,包括青春期开始教育、依从性咨询、应急计划及健康护照,转接约19岁,推荐三种模型,并强调转接后12个月随访要点。
要点
- 过渡应从青春期早期开始,重点教育基因型-表型、触发因素避免和依从性。
- 转接约19岁,可采用联合门诊、分期重叠或虚拟共管三种模型。
- 转接后12个月需短间隔随访、药物核对、再教育和遗传再评估。
核心结论
- 整合的过渡与转接路径可减少可预防的发病,支持年轻IAS患者安全参与教育、职业、妊娠和运动。
研究设计与样本
- 综述,提出适用于不同医疗系统的实用过渡与转接路径。
主要发现
- 过渡和转接常因失访、药物中断及临床和遗传信息传递不完整而复杂化。
- IAS具有年龄和触发因素依赖的风险、药物和器械管理、运动参与、妊娠及心理社会负担等独特复杂性。
- IAS在儿科和成人心脏节律专科培训中占比较小,导致其核心能力存在根本性薄弱。
关键数值与推荐
- 过渡应始于青春期早期,聚焦教育(基因型-表型、触发因素避免)、依从性咨询、应急计划、更新遗传文档和准备度评估,并辅以患者持有的「健康护照」和数字工具。
- 转接通常在约19岁进行,当缺乏专门终身纵向项目时,可采用三种实用模型之一:(i)联合儿科-成人遗传性心律失常门诊;(ii)分期重叠模型,并行访视和温暖交接;(iii)虚拟共管伙伴关系,连接当地成人心脏科团队与区域IAS中心和网络(如欧洲参考网络)。
- 指定的过渡协调员和标准化转接总结对减少信息丢失和改善连续性至关重要。
- 转接后前12个月应包括短间隔随访、药物核对、关于新成人暴露的再教育、遗传再评估和心理社会筛查。
临床怎么用
- 临床应建立从青春期早期开始的计划性过渡,使用健康护照和数字工具支持患者教育。
- 转接时根据资源选择联合门诊、分期重叠或虚拟共管模型,并指定协调员和标准化总结。
- 转接后12个月内加强随访,包括药物核对、再教育、遗传再评估和心理社会筛查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Inherited arrhythmia syndromes (IAS)-including long QT syndrome (LQTS), catecholaminergic polymorphic ventricular tachycardia (CPVT), and Brugada syndrome (BrS)-are important causes of sudden cardiac death in the young. Although molecular diagnosis and cascade screening have improved prevention, adolescence and emerging adulthood remain vulnerable periods. Transition (planned readiness building) and transfer (handoff to adult services) are frequently complicated by loss to follow-up, medication lapses, and incomplete transmission of clinical and genetic information. IAS adds unique complexities, including age- and trigger-dependent risk, medication and device management, sports participation, pregnancy, and psychosocial burden with family implications. In addition, IAS represents a comparatively minor focus of the entire training programme for both paediatric and adult heart rhythm specialists and as such, the very 'home' for patients with IAS has fundamental weaknesses in its underlying competence. This review proposes a pragmatic transition-and-transfer pathway adaptable across healthcare systems. Transition should begin in early adolescence and focus on education (genotype-phenotype, trigger avoidance), adherence counselling, emergency planning, updated genetic documentation, and readiness assessment supported by a patient-held 'Health Passport' and digital tools. Transfer (typically around age 19) should be protected by one of three practical models when a dedicated lifelong longitudinal programme is unavailable: (i) a co-located joint paediatric-adult inherited arrhythmia clinic; (ii) a staged overlap model with parallel visits and warm handoffs; or (iii) a virtual co-management partnership linking local adult cardiology teams with regional IAS centres and networks (e.g. European Reference Networks). A designated transition coordinator and standardized transfer summary are essential to reduce information loss and improve continuity. The first 12 months post-transfer should include short-interval follow-up, medication reconciliation, re-education regarding new adult exposures, genetic re-evaluation, and psychosocial screening. Integrated transition and transfer pathways can reduce preventable morbidity and support safe participation in education, careers, pregnancy, and sport for young people living with IAS.
引用
- Sardana M, MacIntyre C, Giudicessi JR, et al. Paediatric-to-adult transition in inherited arrhythmia syndromes. Eur Heart J. 2026. PMID: 42643086. doi:10.1093/eurheartj/ehag610
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。